Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can Master Craftsmen be mass-produced?

Richard Archer1

  • 1Automation Partnership Ltd, York Way, Royston, Hertfordshire SG8 5WY, UK. richard.archer@automationpartnership.com

Nature Reviews. Drug Discovery
|July 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Internal reflectance cell fluorescence measurement combined with multi-way analysis to detect fluorescence signatures of undiluted honeys and a fusion of fluorescence and NIR to enhance predictability.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2022
Same author

Partial Biodegradable Blend for Fused Filament Fabrication: In-Process Thermal and Post-Printing Moisture Resistance.

Polymers·2022
Same author

Partial Biodegradable Blend with High Stability against Biodegradation for Fused Deposition Modeling.

Polymers·2022
Same author

Development of Bacterial Spore Pouches as a Tool to Evaluate the Sterilization Efficiency-A Case Study with Microwave Sterilization Using <i>Clostridium sporogenes</i> and <i>Geobacillus stearothermophilus</i>.

Foods (Basel, Switzerland)·2020
Same author

Acrylonitrile Butadiene Styrene and Polypropylene Blend with Enhanced Thermal and Mechanical Properties for Fused Filament Fabrication.

Materials (Basel, Switzerland)·2019
Same author

Effect of Material and Process Specific Factors on the Strength of Printed Parts in Fused Filament Fabrication: A Review of Recent Developments.

Materials (Basel, Switzerland)·2019
Same journal

R&D productivity trends for biopharma companies in Asia and emerging markets.

Nature reviews. Drug discovery·2026
Same journal

Growth in clinical research capability in China and impact on the pharmaceutical sector.

Nature reviews. Drug discovery·2026
Same journal

Circular RNA guides exon skipping in DMD.

Nature reviews. Drug discovery·2026
Same journal

p38α inhibition restores axonal transport.

Nature reviews. Drug discovery·2026
Same journal

Inflammatory bowel disease-on-a-chip.

Nature reviews. Drug discovery·2026
Same journal

Designing GPCR-targeted miniproteins.

Nature reviews. Drug discovery·2026
See all related articles

Pharmaceutical companies struggle to achieve productivity gains from new research technologies. Realizing benefits requires significant organizational and workforce skill changes for drug discovery industrialization.

Area of Science:

  • Pharmaceutical research and development
  • Biotechnology innovation

Background:

  • Despite advancements in novel research technologies, the pharmaceutical industry has not met expected productivity improvements.
  • The concept of drug discovery 'industrialization' is explored as a potential solution.

Purpose of the Study:

  • To analyze the reasons behind the failure to achieve productivity gains from new pharmaceutical research technologies.
  • To identify the necessary changes in skills and organization for successful drug discovery industrialization.

Main Methods:

  • Literature review of pharmaceutical R&D productivity trends.
  • Analysis of case studies on technology adoption in drug discovery.
  • Expert interviews on organizational change and skill development.

Related Experiment Videos

Main Results:

  • Novel research technologies have not yielded anticipated productivity increases in pharmaceutical firms.
  • Significant organizational restructuring and upskilling of the workforce are essential for industrialization.
  • Current approaches often neglect the human and organizational elements crucial for technological success.

Conclusions:

  • The successful industrialization of drug discovery is contingent upon holistic changes, not solely technological adoption.
  • Pharmaceutical companies must invest in workforce training and adapt organizational structures to leverage new technologies effectively.
  • Addressing the human capital and organizational aspects is critical for unlocking the full potential of pharmaceutical innovation.